ERAP1 and psoriasis: A European study showed that rs27524A at the ERAP1 variant was associated with psoriasis (p = 0.019, OR = 1.34), especially in pediatric patients, which could be used as an independent risk factor (p = 0.042, OR = 1.43) (Bergboer et al. 2012).